Harvest Declares Big Pharma Split Corp. June 2025 Distributions

Harvest Portfolios Group Inc. has announced significant cash distributions for shareholders of Big Pharma Split Corp. for the month ending June 30, 2025. Class A shareholders (PRM:TSX) will receive a monthly cash distribution of $0.1031 per share, while Preferred shareholders (PRM.PR.A:TSX) will receive a quarterly distribution of $0.1250 per share. Both distributions are scheduled for payment on July 9, 2025, and shareholders must be on record by the close of business on June 30, 2025, to qualify.

As an independent Canadian investment fund manager established in 2009, Harvest has built a robust portfolio managing approximately $6.7 billion in assets focused on long-term wealth preservation through high-quality business investments. The firm's overarching strategy revolves around the application of covered call strategies, available across various ETFs including Equity, Enhanced, Fixed Income, Multi-Asset, Specialty, Digital Assets, and Single Stock ETFs.

Investors interested in more information about the distributions or Harvest’s various investment offerings can visit the company’s website at www.harvestportfolios.com, reach out via email at info@harvestetfs.com, or call toll-free at 1-866-998-8298. Media inquiries should be directed to Caroline Grimont, the Senior Vice President of Marketing, at cgrimont@HarvestETFs.com.

It’s essential to note that investing in funds involves certain risks, including potential brokerage fees and fluctuations in share values. There are ongoing fees and expenses associated with investment ownership, and investors should consider the fund's disclosure documents to better understand key information. Overall, Harvest continues to maintain its commitment to helping investors achieve lasting financial growth.

Harvest Portfolios Group Inc. recently disclosed the monthly cash distribution for Big Pharma Split Corp., amounting to CAD 0.1031 per Class A share and CAD 0.1250 per Preferred share, both payable on July 9, 2025. This announcement solidifies Harvest's commitment to providing consistent returns to its investors, particularly in the healthcare sector, which has shown resilience amid market fluctuations.

Investors should view this distribution as a signal of Harvest’s stable management and the robust performance of its underlying pharmaceutical assets. The healthcare sector remains attractive due to its relative immunity to economic downturns and evolving demand driven by demographic trends. As healthcare innovations advance and the global population ages, companies in this sector could experience significant growth.

For Class A shareholders, the monthly dividend provides a regular income stream, which can be particularly appealing in a low-interest environment. Meanwhile, the quarterly distribution for Preferred shareholders not only represents a more substantial payout but also reflects the company’s focus on delivering value to different categories of investors.

It's crucial to consider the performance trends and valuation metrics of Big Pharma Split Corp. when evaluating this investment. Monitoring its net asset value (NAV) in relation to the distributions can provide insights into potential upside or risks.

As Harvest is known for its covered call strategies, investors might also assess the level of risk in the current market environment. The uncertainty in global economic recovery and potential regulatory challenges in the pharmaceutical sector could impact future distributions.

In conclusion, while the distributions are promising, prospective investors should remain vigilant, considering their investment goals and the overall market climate before committing capital. Regularly review Harvest’s updates and performance reports for informed decision-making.